Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
The protein encoded by TNFAIP6 is a secretory protein that contains a hyaluronan-binding domain, and thus is a member of the hyaluronan-binding protein family. De plus, nous expédions Tumor Necrosis Factor-Inducible Protein 6 Kits (40) et Tumor Necrosis Factor-Inducible Protein 6 Protéines (6) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 39 products:
Human Polyclonal TNFAIP6 Primary Antibody pour IHC, IHC (p) - ABIN4363082
Eikrem, Strauss, Beisland, Scherer, Landolt, Flatberg, Leh, Beisvag, Skogstrand, Hjelle, Shresta, Marti: Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing. dans Scandinavian journal of urology 2016
This study provided the first evidence of TSG-6 secreted by mesenchymal stem cells promoting corneal epithelial wound healing in diabetic mice through activating corneal epithelial stem/progenitor cells and accelerating M2 macrophage polarization
This study shows that TSG-6 is expressed in the CNS, suggesting a role for TSG-6 in astrocyte activation and tissue repair.
Data (including data from studies in knockout mice) suggest that TSG-6 is needed for release of hyaluronan rafts (leukocyte-adhesive rafts) from apical surface of tracheal mucosa into bronchoalveolar lavage fluid as heavy chain hyaluronan complexes.
the well characterized hyaluronan-binding site in the TSG-6 Link module is not used for recognition during transfer of HCs (Montrer HLCS Anticorps) onto HA.
Thus, TSG6, HA, and IalphaI were crucial factors for the settlement and probably the subsequent differentiation of MSCs.
BM-MSCs injected into mice with colitis do not localize to the intestine but instead form aggregates in the peritoneum where they produce immunoregulatory molecules, including TSG6, that reduce intestinal inflammation.
This study demonstrated that following stimulation with TNF-alpha (Montrer TNF Anticorps), MSCs modulate microglia activity through TSG-6.
suggest that TSG-6 plays an important role in MSCs-mediated immunosuppressive effect on DC
This study provides insight into what we believe to be a previously undescribed multifaceted role of mesenchymal stem cell-released TSG-6 in wound healing.
TSG-6 is implicated in the experimental murine model of allergic pulmonary inflammation and is likely to contribute to the pathogenesis of asthma
This review will focus on the potential of mesenchymal stem/stromal cells for treatment of fibrotic diseases, with emphasis on the role of TSG-6 as a mediator of anti-inflammatory effects
Single nucleotide polymorphism in TNFAIP6 gene is associated with Systemic lupus erythematosus.
TNFAIP6 expression is significantly upregulated in human masticatory mucosa during wound healing
Data show that TNF (Montrer TNF Anticorps)-stimulated gene-6 (TSG-6) interacts with chemokines through their glycosaminoglycans (GAGs)-binding sites and inhibits their binding to GAGs and endothelial cell surfaces.
The current study describes a novel mechanism linking the TSG-6 transfer of the newly described HC5 (Montrer PSMB1 Anticorps) to the HA-dependent control of cell phenotype. The interaction of HC5 (Montrer PSMB1 Anticorps) with cell surface HA was essential for TGFbeta1 (Montrer TGFB1 Anticorps)-dependent differentiation of fibroblasts to myofibroblasts, highlighting its importance as a novel potential therapeutic target.
Data postulate that the molecular cross-linking enhanced by the multiple binding modes of the Link module might be critical for remodeling the ECM (Montrer MMRN1 Anticorps) during inflammation/ovulation and might contribute to other functions of TSG-6.
TSG-6 exhibited anti-inflammatory effects during the wound healing process and cicatrization and significantly diminished hypertrophic scar formation in a rabbit ear model
results suggest that systemic administration of hASC (Montrer PYCARD Anticorps) or TSG-6 may be novel approaches to reverse CS-induced myelosuppression.
TSG-6 activity in tissues, was examined.
The protein encoded by this gene is a secretory protein that contains a hyaluronan-binding domain, and thus is a member of the hyaluronan-binding protein family. The hyaluronan-binding domain is known to be involved in extracellular matrix stability and cell migration. This protein has been shown to form a stable complex with inter-alpha-inhibitor (I alpha I), and thus enhance the serine protease inhibitory activity of I alpha I, which is important in the protease network associated with inflammation. This gene can be induced by proinflammatory cytokines such as tumor necrosis factor alpha and interleukin-1. Enhanced levels of this protein are found in the synovial fluid of patients with osteoarthritis and rheumatoid arthritis.
tumor necrosis factor alpha induced protein 6
, tumor necrosis factor-inducible gene 6 protein
, tumor necrosis factor-inducible protein 6
, TNF alpha-induced protein 6
, TNF-stimulated gene 6 protein
, tumor necrosis factor alpha-induced protein 6
, tumor necrosis factor induced protein 6
, tumor necrosis factor, alpha-induced protein 6
, hyaluronate-binding protein
, tumor necrosis factor alpha-inducible protein 6
, tumor necrosis factor-stimulated gene-6 protein
, hyaluronate-binding protein PS4
, secreted hyaluronate binding protein